Kiniksa Pharmaceuticals (KNSA) Enterprise Value
Price: $20.36
Market Cap: $1.48B
Avg Volume: 601.68K
Market Cap: $1.48B
Avg Volume: 601.68K
Country: BM
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Kiniksa Pharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is 1.24B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 1.41B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $19.78, with 71.42M shares outstanding.
- The company has 183.58M in cash and cash equivalents and 9.86M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$1.24B
Market Cap
$1.41B
Total Debt
$9.86M
Cash and Equivalents
$183.58M
Historical Enterprise Value
Kiniksa Pharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $1.24B | -27.36% | $19.78 | 71.42M | $1.41B | $183.58M | $9.86M |
| September 30, 2024 | $1.71B | 43.31% | $24.99 | 71.73M | $1.79B | $97.38M | $10.60M |
| June 30, 2024 | $1.19B | -5.73% | $18 | 71.00M | $1.28B | $99.27M | $11.40M |
| March 31, 2024 | $1.26B | 10.88% | $19.7 | 70.63M | $1.39B | $141.08M | $12.14M |
| December 31, 2023 | $1.14B | 2.19% | $17.54 | 70.37M | $1.23B | $107.95M | $12.26M |
| September 30, 2023 | $1.11B | 25.85% | $17.37 | 70.19M | $1.22B | $117.83M | $12.96M |
| June 30, 2023 | $885.40M | 31.07% | $14.08 | 69.92M | $984.45M | $112.57M | $13.52M |
| March 31, 2023 | $675.53M | -27.05% | $10.76 | 69.75M | $750.53M | $80.62M | $5.62M |
| December 31, 2022 | $925.95M | 28.14% | $14.98 | 69.61M | $1.04B | $122.72M | $5.92M |
| September 30, 2022 | $722.62M | 25.03% | $12.84 | 69.45M | $891.67M | $175.76M | $6.71M |
| June 30, 2022 | $577.95M | -8.16% | $9.69 | 68.90M | $667.64M | $94.31M | $4.61M |
| March 31, 2022 | $629.30M | -9.50% | $9.94 | 69.14M | $687.22M | $63.32M | $5.41M |
| December 31, 2021 | $695.37M | 16.16% | $11.77 | 68.97M | $811.79M | $122.47M | $6.05M |
| September 30, 2021 | $598.63M | -23.97% | $11.39 | 68.66M | $782.07M | $190.18M | $6.75M |
| June 30, 2021 | $787.32M | -31.56% | $13.93 | 68.14M | $949.14M | $167.95M | $6.14M |
| March 31, 2021 | $1.15B | 5.00% | $18.51 | 68.27M | $1.26B | $119.86M | $6.57M |
| December 31, 2020 | $1.10B | 18.30% | $17.67 | 68.06M | $1.20B | $114.04M | $6.99M |
| September 30, 2020 | $926.16M | -31.60% | $15.32 | 65.96M | $1.01B | $85.87M | $1.55M |
| June 30, 2020 | $1.35B | 79.98% | $25.48 | 57.91M | $1.48B | $123.46M | $1.82M |
| March 31, 2020 | $752.30M | 33.68% | $15.48 | 55.32M | $856.40M | $106.34M | $2.24M |
| December 31, 2019 | $562.78M | 166.89% | $11.06 | 54.89M | $607.06M | $46.93M | $2.65M |
| September 30, 2019 | $210.87M | -52.41% | $8.51 | 54.83M | $466.61M | $258.75M | $3.00M |
| June 30, 2019 | $443.12M | -26.52% | $13.35 | 54.48M | $727.25M | $287.45M | $3.31M |
| March 31, 2019 | $603.05M | -42.78% | $17.89 | 51.76M | $925.96M | $326.53M | $3.62M |
| December 31, 2018 | $1.05B | 29.36% | $28.09 | 48.46M | $1.36B | $307.30M | $- |
| September 30, 2018 | $814.68M | 2408.28% | $23.92 | 48.18M | $1.15B | $337.86M | $- |
| June 30, 2018 | $32.48M | -95.31% | $17.35 | 18.33M | $318.00M | $285.52M | $- |
| March 31, 2018 | $693.26M | 18.19% | $19.47 | 46.96M | $914.37M | $221.11M | $- |
| December 31, 2017 | $586.58M | -7.21% | $19.47 | 32.47M | $632.13M | $45.55M | $- |
| September 30, 2017 | $632.13M | 0.00% | $19.47 | 32.47M | $632.13M | $- | $- |
| June 30, 2017 | $632.13M | -8.13% | $19.47 | 32.47M | $632.13M | $- | $- |
| March 31, 2017 | $688.10M | - | $19.47 | 32.47M | $632.13M | $-55.97M | $- |
Related Metrics
Explore detailed financial metrics and analysis for KNSA.